Buscar resultados de ensayos clínicos

Patrocinado por

Leishmaniasis - 70 Studies Found

Estado Estudiar
Completed Nombre del estudio: Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia
Condición: Cutaneous Leishmaniasis
Fecha: 2013-04-24
Intervenciones: Drug: Topical Amphotericin B at 3% Other Name: Anfoleish
Not yet recruiting Nombre del estudio: Miltefosine and GM-CSF in Cutaneous Leishmaniasis
Condición: Cutaneous Leishmaniasis
Fecha: 2016-12-27
Intervenciones:
  • Drug: Sbv Standard treatment f
Completed Nombre del estudio: Antimony Plus Pentoxifylline in Cutaneous Leishmaniasis
Condición: Cutaneous Leishmaniasis
Fecha: 2011-06-23
Intervenciones:
  • Drug: Pentoxifylline Patients

Completed Nombre del estudio: WR 279,396 for the Treatment of Cutaneous Leishmaniasis
Condición: Cutaneous Leishmaniasis
Fecha: 2013-11-14
Intervenciones: Drug: WR 279,396 Paromomycin + Gentamicin Topical Cream
Completed Nombre del estudio: Efficacy and Safety of Pentamidine (7mg/kg) for Patients With Cutaneous Leishmaniasis Caused by L. Guyanensis
Condición: Cutaneous Leishmaniasis.
Fecha: 2016-03-04
Intervenciones:
  • Drug: Single dose of Pentacarinat®

Completed Nombre del estudio: Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis
Condición: Cutaneous Leishmaniasis
Fecha: 2006-04-21
Intervenciones:
  • Drug: Meglumine antimoniate Me
Active, not recruiting Nombre del estudio: Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous Leishmaniasis
Condición: Cutaneous Leishmaniasis
Fecha: 2011-02-20
Intervenciones: Drug: Meglumine antimoniate Meglumine antimoniate is store
Active, not recruiting Nombre del estudio: Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia
Condición: Cutaneous Leishmaniasis
Fecha: 2007-06-14
Intervenciones:
  • Drug: Miltefosine Oral Miltefo
Completed Nombre del estudio: Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in Panama
Condición: Cutaneous Leishmaniasis
Fecha: 2013-02-05
Intervenciones:
  • Drug: WR 279,396 WR 279,396 is
Completed Nombre del estudio: Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants
Condición: Cutaneous Leishmaniasis
Fecha: 1999-11-03
Intervenciones: Biological: Combination of autoclaved leishmania antigen with recombinant human interleukin-12 (rhIL-12) and aluminum hydroxide gel as adjuvants
<<< Previous | Next >>>